LONDON, October 9, 2017 /PRNewswire/ — Researchers from the UCL Cancer Institute and the specialist healthcare company BTG plc (LSE: BTG) have begun the first clinical trial of an experimental treatment for liver cancer using X-ray imageable microscopic beads loaded with a targeted anti-cancer drug placed directly in the liver. The trial […]
Author: Ken Dropiewski
Essential Medical Release: The MANTA Large Bore Vascular Closure Device To Be Evaluated In A 500-Patient European Post Market Clinical Registry
EXTON, Pennsylvania, Oct. 9, 2017 /PRNewswire/ –Essential Medical, Inc. today announced initiation of enrollment in a post market clinical registry in the regions where MANTA is commercially available. Principle Investigator Nicolas Van Mieghem, MD, PhD, Medical Director of the Department of Interventional Cardiology at Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands stated, “MANTA has quickly become […]
MRI Interventions (MRIC) Names Former Royal Philips Electronics N.V. (PHG) Exec as New CEO
IRVINE, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced the appointment of Joseph Burnett as President and CEO, effective November 7. The company’s current President and CEO, Frank Grillo, will continue in the role until November 6, and will serve as an executive advisor to […]
Medtronic (MDT)’s Stent System Wins FDA OK to Treat Short Neck Anatomies When Used With Heli-FX EndoAnchor System
DUBLIN – October 9, 2017 – Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the Endurant(TM) II/IIs stent graft system to treat abdominal aortic aneurysm (AAA) patients with neck lengths down to 4mm and <=60° infra-renal angulation when used in combination […]
Endologix Receives IDE Approval For The EVAS2 Confirmatory Clinical Study To Evaluate The Nellix Endovascular Aneurysm Sealing System
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that it has received Investigational Device Exemption (“IDE”) approval from the United States Food and Drug Administration (“FDA”) to commence a confirmatory clinical study to evaluate the safety and effectiveness of the Nellix […]
FDA Grants Marketing Clearance for the Peerbridge Cor™ Multi-channel Remote ECG Monitor
NEW YORK, Oct. 4, 2017 /PRNewswire/ — Peerbridge Health Inc., a Health IT company, announced today that its first product, the Peerbridge Cor™ System — a wireless electrocardiogram (ECG) monitor — has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The patented Peerbridge Cor has the smallest on-body footprint of any […]
Cardiologs Raises $6.4 Million to Lead the AI Revolution in Cardiology
PARIS & SAN FRANCISCO–(BUSINESS WIRE)–Cardiologs Technologies announced today that it has raised $6.4 million in a Series A financing with a syndicate of life science and technology investors (Idinvest, ISAI, Kurma Partners, Partech Ventures) and with continued support and participation from current investor Bpifrance seed fund (F3A). This round brings total […]
BTG to buy Roxwood Medical for up to $80 million
UK’s BTG to buy Roxwood Medical for up to $80 million Reuters Staff Reporting by Radhika Rukmangadhan in Bengaluru; editing by Jason Neely Our Standards:The Thomson Reuters Trust Principles. (Reuters) – British drugs company BTG Plc (BTG.L) said on Thursday it will buy U.S.-based cardiovascular catheter maker Roxwood Medical for […]
ROX Medical CONTROL HTN-2 Clinical Trial; First Procedure Performed
SAN CLEMENTE, Calif., October 3, 2017 – ROX Medical Inc. A privately held medical device company pioneering an innovative interventional vascular therapy for Uncontrolled Hypertension, announced today that the first patient was treated in the CONTROL HyperTeNsion (HTN)-2 clinical study, the Company’s pivotal study to evaluate the safety and effectiveness of […]
Bolton Medical Announces the First Implant of the Relay®Pro Clinical Trial for Treatment of Thoracic Aortic Dissections
Sunrise, Fla, October 3, 2017 – Bolton Medical announced the first patient has been enrolled in the RelayPro FDA Phase II Clinical Trial for Treatment of Acute Complicated Type B Thoracic Aortic Dissections. This trial will assess the safety and efficacy of RelayPro to treat Type B dissections. Christian Shults, M.D., Cardiothoracic […]



